Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells

[1]  R. Gold,et al.  Termination of inflammation in the nervous system. , 2007, Revue neurologique.

[2]  Cristina Muñoz-Pinedo,et al.  Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Glimcher,et al.  Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells , 2006, Nature Immunology.

[4]  A. Hoffmann,et al.  Circuitry of nuclear factor κB signaling , 2006 .

[5]  Keisuke Kuida,et al.  Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis , 2006, Science.

[6]  L. Glimcher,et al.  T-bet-dependent expression of osteopontin contributes to T cell polarization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Letterio.  TGF-β signaling in T cells: roles in lymphoid and epithelial neoplasia , 2005, Oncogene.

[8]  T. Hibi,et al.  Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response , 2005, Gut.

[9]  D. Baker,et al.  Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice , 2005, Journal of Neuroimmunology.

[10]  C. Lam,et al.  Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. , 2005, Rheumatology.

[11]  H. Nie,et al.  Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. , 2005, The Journal of clinical investigation.

[12]  E. Lam,et al.  Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells , 2005, Oncogene.

[13]  X. Montalban,et al.  Plasma osteopontin levels in multiple sclerosis , 2005, Journal of Neuroimmunology.

[14]  A. Strasser,et al.  T-lymphocyte death during shutdown of an immune response. , 2004, Trends in immunology.

[15]  C. Polman,et al.  Osteopontin levels and increased disease activity in relapsing–remitting multiple sclerosis patients , 2004, Journal of Neuroimmunology.

[16]  B. Fang,et al.  Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells , 2004, Leukemia.

[17]  Ryuji Kobayashi,et al.  IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.

[18]  A. Chiocchetti,et al.  High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. , 2003, Blood.

[19]  G. Kundu,et al.  Osteopontin Stimulates Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells* , 2003, Journal of Biological Chemistry.

[20]  H. Weiner,et al.  Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis , 2003, The Journal of experimental medicine.

[21]  P. Marrack,et al.  Control of T cell viability. , 2003, Annual review of immunology.

[22]  R. Dai,et al.  Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsing–remitting EAE in H-2b/s mice , 2003, Journal of Neuroimmunology.

[23]  L. Nicoll.  Teaching an old dog new tricks. , 2003, Computers, informatics, nursing : CIN.

[24]  S. Youssef,et al.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.

[25]  S. Lipton,et al.  Dueling Activities of AIF in Cell Death versus Survival DNA Binding and Redox Activity , 2002, Cell.

[26]  L. Klein,et al.  Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice1 , 2002, The Journal of Immunology.

[27]  Yi-hung Lin,et al.  The Osteopontin-CD44 Survival Signal Involves Activation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway* , 2001, The Journal of Biological Chemistry.

[28]  Jorge R. Oksenberg,et al.  The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease , 2001, Science.

[29]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[30]  Lawrence Steinman,et al.  Multiple sclerosis: a two-stage disease , 2001, Nature Immunology.

[31]  G. V. van Seventer,et al.  IL-12 Decreases Activation-Induced Cell Death in Human Naive Th Cells Costimulated by Intercellular Adhesion Molecule-1. I. IL-12 Alters Caspase Processing and Inhibits Enzyme Function1 , 2001, The Journal of Immunology.

[32]  B. Adler,et al.  Costimulation by extracellular matrix proteins determines the response to TCR ligation. , 2001, Cellular immunology.

[33]  M. Noda,et al.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. , 2001, The Journal of clinical investigation.

[34]  G. Nau,et al.  Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. , 2000, Immunology today.

[35]  M. Zöller,et al.  Abrogation of Experimental Colitis Correlates with Increased Apoptosis in Mice Deficient for Cd44 Variant Exon 7 (Cd44v7) , 2000, The Journal of experimental medicine.

[36]  G. Screaton,et al.  T cell life and death signalling via TNF-receptor family members. , 2000, Current Opinion in Immunology.

[37]  R. Medema,et al.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 , 2000, Nature.

[38]  Yi-hung Lin,et al.  Coupling of Osteopontin and Its Cell Surface Receptor CD44 to the Cell Survival Response Elicited by Interleukin-3 or Granulocyte-Macrophage Colony-Stimulating Factor , 2000, Molecular and Cellular Biology.

[39]  M. Glimcher,et al.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.

[40]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[41]  R. Atkins,et al.  IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. , 1999, The American journal of pathology.

[42]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[43]  N. Fausto,et al.  NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival , 1998, The Journal of cell biology.

[44]  Hans Lassmann,et al.  T-cell apoptosis in autoimmune diseases: termination of inf lammation in the nervous system and other sites with specialized immune-defense mechanisms , 1997, Trends in Neurosciences.

[45]  V. Tuohy,et al.  A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease , 1996, The Journal of experimental medicine.

[46]  M. Pender,et al.  Apoptotic elimination of Vβ8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vβ8.2+ encephalitogenic T cells , 1994 .

[47]  L. Steinman,et al.  Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.

[48]  H. Cantor,et al.  Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. , 1991, Journal of immunology.

[49]  M. Pender,et al.  Apoptosis in the nervous system in experimental allergic encephalomyelitis , 1991, Journal of the Neurological Sciences.

[50]  J. Letterio.  TGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia. , 2005, Oncogene.

[51]  L. Steinman,et al.  Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. , 2002, Annual review of neuroscience.

[52]  A. Abbas,et al.  The enemy within: keeping self-reactive T cells at bay in the periphery , 2002, Nature Reviews Immunology.

[53]  M Bockarie,et al.  Review of the Multilateral Initiative on Malaria [MIM]. Final report. Monday through Friday September 30th - October 4th 2002 Fogarty International Center National Institutes of Health Bethesda Maryland. , 2002 .

[54]  N. Fausto,et al.  NF-k B Mediates a v b 3 Integrin-induced Endothelial Cell Survival , 1998 .